(2026). Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients. Endocrine Journal.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Efficacy and Safety of Dabrafenib Plus Trametinib in BRAFV600E-mutated Advanced Thyroid Carcinoma: Real World Experience in 37 Patients."
Endocrine Journal 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Efficacy and Safety of Dabrafenib Plus Trametinib in BRAFV600E-mutated Advanced Thyroid Carcinoma: Real World Experience in 37 Patients."
Endocrine Journal, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.